X

Trial Profile

A Randomised, Double-blind, Placebo-controlled, Dose-response Study of the Efficacy and Safety of MEDI7352 in Subjects With Painful Osteoarthritis of the Knee

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 27 Sep 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MEDI 7352 (Primary)
Indications Musculoskeletal pain
Focus Therapeutic Use
Acronyms BESPOKE
Sponsors AstraZeneca

Most Recent Events

04 Sep 2023 Status changed from active, no longer recruiting to completed.
21 Apr 2023 Planned End Date changed from 14 Aug 2023 to 18 Aug 2023.
21 Apr 2023 Planned primary completion date changed from 14 Aug 2023 to 18 Aug 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com